02 Jan 2020
My five top trials in interventional cardiology in 2019: impact on clinical practice?
A look at COMPLETE, BIOSTEMI, EXCEL, ISAR REACT 5, PARTNER 3/EVOLUT Low Risk
Chairpersons:
I. Al Rashdan, H. Amin
Speaker:
A. Baumbach
Summary
Consult this session to learn all about the latest evidence from trials relevant for interventional cardiology, selected by EAPCI President Andreas Baumbach, and discover their impact on your daily practice: COMPLETE, BIOSTEMI, EXCEL, and more!
Learning Objectives
- To review together the latest evidence from trials relevant for interventional cardiology
- To discuss the potential impact of the trial outcomes on your practice
- To understand the potential relevance of these trials for practice guidelines
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide011.jpg)
/slide012.jpg)
/slide013.jpg)
/slide014.jpg)
/slide015.jpg)
/slide016.jpg)
/slide017.jpg)
/slide018.jpg)
/slide019.jpg)
/slide020.jpg)
/slide021.jpg)
/slide022.jpg)
/slide023.jpg)
/slide024.jpg)
/slide025.jpg)
/slide026.jpg)
/slide027.jpg)
/slide028.jpg)
/slide029.jpg)
/slide030.jpg)
/slide031.jpg)
/slide032.jpg)
/slide033.jpg)
/slide034.jpg)
/slide035.jpg)
/slide036.jpg)
/slide037.jpg)
/slide038.jpg)
/slide039.jpg)
/slide040.jpg)
/slide041.jpg)
/slide042.jpg)
/slide043.jpg)
/slide044.jpg)
/slide045.jpg)
/slide046.jpg)
/slide047.jpg)
/slide048.jpg)
/slide049.jpg)
/slide050.jpg)
/slide051.jpg)
/slide052.jpg)
/slide053.jpg)
/slide054.jpg)
/slide055.jpg)
/slide056.jpg)
/slide057.jpg)
/slide058.jpg)
/slide059.jpg)
/slide060.jpg)
/slide061.jpg)
/slide062.jpg)
/slide063.jpg)
/slide064.jpg)
/slide065.jpg)
/slide066.jpg)
/slide067.jpg)
/slide068.jpg)
/slide069.jpg)
/slide070.jpg)
/slide071.jpg)
/slide072.jpg)
/slide073.jpg)
/slide074.jpg)
/slide075.jpg)
/slide076.jpg)
/slide077.jpg)
/slide078.jpg)
/slide079.jpg)
